2011
DOI: 10.1176/appi.ajp.2011.10111704
|View full text |Cite
|
Sign up to set email alerts
|

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

Abstract: Objective Research on suicide prevention and interventions requires a standard method for assessing both suicidal ideation and behavior to identify those at risk and to track treatment response. The Columbia–Suicide Severity Rating Scale (C-SSRS) was designed to quantify the severity of suicidal ideation and behavior. The authors examined the psychometric properties of the scale. Method The C-SSRS’s validity relative to other measures of suicidal ideation and behavior and the internal consistency of its inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

25
2,631
3
41

Year Published

2012
2012
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 3,799 publications
(2,844 citation statements)
references
References 41 publications
25
2,631
3
41
Order By: Relevance
“…This is consistent with other suicide risk assessment tools, such as the Columbia Suicide Severity Rating Scale, which recommends referrals for inmates with ideation and at least some intent (Posner et al, 2011). While clinical interventions would be desirable to develop risk management plans for inmates reporting the items in models 2 through 7, this may not always be feasible.…”
Section: Discussionsupporting
confidence: 69%
“…This is consistent with other suicide risk assessment tools, such as the Columbia Suicide Severity Rating Scale, which recommends referrals for inmates with ideation and at least some intent (Posner et al, 2011). While clinical interventions would be desirable to develop risk management plans for inmates reporting the items in models 2 through 7, this may not always be feasible.…”
Section: Discussionsupporting
confidence: 69%
“…The smoker characteristics examined were: country of study site (USA versus non‐USA); history of psychiatric diagnosis (defined as the primary diagnosis: none, mood disorder, anxiety disorder, psychotic disorder); sex; age; BMI; ethnic group (white, black, other); lifetime suicidal ideation and/or behaviour [none versus any, captured through Columbia–Suicide Severity Rating Scale (C‐SSRS)] 28; anxiety score [Hospital Anxiety and Depression scale (HADS)] 29; depression score (HADS) 29; aggression score [Buss–Perry Aggression Questionnaire (BPAQ)] 30; use of psychotropic medication, including sleeping aids (none, any); cigarette dependence [Fagerström Test for Cigarette Dependence (FTCD)] 31; age of starting smoking; and prior use of study medicines (none versus any, for each of the three medications—varenicline, bupropion or any type of NRT). Supporting information, Table S2 describes the collection of smokers’ characteristics as recorded on the patient report form used by investigators.…”
Section: Methodsmentioning
confidence: 99%
“…[48][49][50][51][52] Psychiatric symptomrelated information was collected using the Brief Psychiatric Rating Scale (BPRS), 53 Scale for Assessment of Negative Symptoms (SANS), 54 Clinical Global Impression (CGI) 55 scale, and Beck Depression Inventory (BDI-II). 56 To evaluate issues related to safety, the ColumbiaSuicide Severity Rating Scale (C-SSRS) 57 and Abnormal Involuntary Movement Scale (AIMS) 58 were also administered.…”
Section: Baseline and Treatment-related Assessmentsmentioning
confidence: 99%